Clinical trials for Juvenile idiopathic arthritis
34 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ENROLLING BY INVITATIONPhase 3NCT07386587Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic ArthritisUniversity of Child Health Sciences and Children's Hospital, Lahore · PI: Faisal Haneef
- RECRUITINGPhase 3NCT06654882Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisDuke University
- RECRUITINGNCT07243782Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaNovartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- RECRUITINGN/ANCT07217782Pain in Juvenile ArthritisWashington University School of Medicine · PI: Hadas Nahman-Averbuch, PhD
- RECRUITINGNCT07185750Investigation of Catastrophizing of Pain Reported by Parents in JIA PatientsHacettepe University
- RECRUITINGNCT06806774Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic ArthritisHacettepe University · PI: Sinan Buran, MSc
- RECRUITINGN/ANCT07234747Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic ArthritisIstanbul University - Cerrahpasa · PI: Nilay Arman, Assoc. Prof. Dr.
- RECRUITINGN/ANCT06474546Feasibility of a Diet Intervention for Juvenile ArthritisThe Hospital for Sick Children · PI: Brian M. Feldman
- RECRUITINGNCT06870045Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIAIstanbul University - Cerrahpasa
- RECRUITINGN/ANCT06874608Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic ArthritisMeyer Children's Hospital IRCCS
- RECRUITINGPhase 4NCT06653634Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA TrialOslo University Hospital · PI: Anna-Birgitte Aga, MD PhD
- RECRUITINGN/ANCT06376149M3-JIA: Making Mindfulness Matter for Children With JIALondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · PI: Roberta Berard, MD
- RECRUITINGN/ANCT06546293Core Stabilization Training in Juvenile SpondyloarthropathyIstanbul University - Cerrahpasa
- RECRUITINGNCT05547451SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic ArthritisNantes University Hospital
- RECRUITINGPhase 1NCT06222034Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)Alfasigma S.p.A. · PI: Alfasigma Study Director
- RECRUITINGPhase 3NCT06463379The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic ArthritisSohag University
- RECRUITINGNCT05754710Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic ArthritisPfizer · PI: Pfizer CT.gov Call Center
- RECRUITINGNCT06862843Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.Meyer Children's Hospital IRCCS
- RECRUITINGN/ANCT06184100Virtual Self-Management Program for JIAUniversity of Calgary
- RECRUITINGN/ANCT05925452To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.Changchun GeneScience Pharmaceutical Co., Ltd.
- RECRUITINGPhase 3NCT05609630Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.AbbVie · PI: ABBVIE INC.
- RECRUITINGN/ANCT04806620Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchBrain Inflammation Collaborative · PI: Megan L Fitzgerald, PhD
- RECRUITINGN/ANCT05310799Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIAUniversity of British Columbia · PI: Lori B Tucker, MD
- RECRUITINGNCT05534347Angiogenic Biomarkers in Juvenile Idiopathic ArthritisAssistance Publique - Hôpitaux de Paris · PI: Yannick ALLANORE, PD, PhD
- RECRUITINGNCT05176795Host-microbiota-environment InteractionsUniversity Hospital, Clermont-Ferrand · PI: Etienne Merlin
- RECRUITINGNCT06007456Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic ArthritisIRCCS Burlo Garofolo · PI: Serena Pastore, MD
- RECRUITINGPhase 3NCT04088396A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)Eli Lilly and Company · PI: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
- ACTIVE NOT RECRUITINGPhase 1NCT03725007A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic ArthritisAbbVie · PI: ABBVIE INC.
- RECRUITINGN/ANCT03913962Health and Exercise Response in Children With Chronic and Auto-immune PathologiesUniversity Hospital, Clermont-Ferrand · PI: Etienne MERLIN
- RECRUITINGNCT06560606UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic DiseaseThe Hospital for Sick Children · PI: Rae SM Yeung, MD, PhD, FRCPC
- RECRUITINGPhase 2NCT02991469A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)Sanofi · PI: Clinical Sciences & Operations
- RECRUITINGNCT03245801CAPRI National Juvenile Idiopathic Arthritis RegistryUniversity of British Columbia · PI: Jaime Guzman, MD, FRCPC
- RECRUITINGNCT07000916Medical Follow-up of New Cases of Polyarthritis in Children and Young AdultsUniversité Catholique de Louvain · PI: Patrick Durez, Pr
- ACTIVE NOT RECRUITINGNCT01357668An Observational Registry of Abatacept in Patients With Juvenile Idiopathic ArthritisBristol-Myers Squibb · PI: Bristol-Myers Squibb